Fiduciary Family Office’s Boston Scientific BSX Stock Holding History

Fiduciary Family Office’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.41M	Buy	22,536 +12,875	+133%	+$1.03M	0.4%	50
2025 Q4	$921K	Sell	9,661 -126	-1%	-$12.4K	0.26%	68
2025 Q3	$956K	Sell	9,787 -3,699	-27%	-$383K	0.27%	74
2025 Q2	$1.45M	Sell	13,486 -750	-5%	-$75.9K	0.47%	41
2025 Q1	$1.44M	Buy	+14,236	New	+$1.43M	0.48%	40
2024 Q4	–	Sell	-11,956	Closed	-$1M	–	104
2024 Q3	$1M	Sell	11,956 -1,186	-9%	-$93.5K	0.33%	65
2024 Q2	$1.01M	Sell	13,142 -1,370	-9%	-$100K	0.4%	64
2024 Q1	$994K	Buy	14,512 +4,359	+43%	+$280K	0.39%	68
2023 Q4	$587K	Buy	+10,153	New	+$542K	0.26%	96

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fiduciary Family Office's BSX Position: Q1 2026 in Review

Fiduciary Family Office increased its Boston Scientific (BSX) stake by 133% in Q1 2026, buying an estimated $1.03M and bringing the position to 22,536 shares worth $1.41M. The position accounts for 0.4% of the portfolio, ranked #50.

Fiduciary Family Office first reported a position in BSX in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.45M in Q2 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Fiduciary Family Office held 22,536 shares of Boston Scientific worth $1.41M as of Q1 2026.
Fiduciary Family Office bought 12,875 Boston Scientific shares in Q1 2026, an estimated $1.03M.
Boston Scientific made up 0.4% of Fiduciary Family Office's portfolio in Q1 2026, its #50 holding.
Fiduciary Family Office first reported a position in Boston Scientific in Q4 2023 and has held it in 9 quarters since.
Fiduciary Family Office's Boston Scientific position peaked at $1.45M in Q2 2025.
1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.